Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06635824
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-08
Brief Title:
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer ABBIL1TY NSCLC-06
Sponsor:
Organization:
None